The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.
 
Robert R. McWilliams
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Andrew H. Ko
Consulting or Advisory Role - ARMO Biosciences; Celgene; Incyte; Merrimack; Oncogenex; Threshold Pharmaceuticals
Research Funding - Aduro Biotech (Inst); Celgene (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); PharmaEngine (Inst); PRISM BioLab (Inst); Seagen (Inst)
 
E. Gabriela Chiorean
Research Funding - PRISM Pharma (Inst)
 
Eunice Lee Kwak
Research Funding - PRISM Pharma (Inst)
 
Heinz-Josef Lenz
Honoraria - Bayer; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Celgene; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Paul I. Nadler
Employment - Nadler Pharma Associates
Leadership - Nadler Pharma Associates
Stock and Other Ownership Interests - Hansen Medical; Vanda Pharmaceuticals
Consulting or Advisory Role - Biscayne Pharmaceuticals; Dicerna; Immune Design; Karyopharm Therapeutics; OncoTherapy Science; PRISM Pharma; Raptor Pharmaceuticals; Spectrum Pharmaceuticals
 
Debra L Wood
Employment - Nadler Pharma Associates
Leadership - Nadler Pharma Associates
Stock and Other Ownership Interests - Hansen Medical; Vanda Pharmaceuticals
Consulting or Advisory Role - Aurigene Discovery Technologies; Dicerna; OncoTherapy Science; PRISM Pharma
 
Masamoto Fujimori
Stock and Other Ownership Interests - PRISM Pharma
Consulting or Advisory Role - PRISM Pharma
 
Kohei Morita
Employment - PRISM Pharma
Stock and Other Ownership Interests - PRISM Pharma
Travel, Accommodations, Expenses - PRISM Pharma
 
Tetsuhi Inada
Consulting or Advisory Role - PRISM Pharma
 
Hiroyuki Kouji
Employment - PRISM Pharma
Leadership - PRISM Pharma
Stock and Other Ownership Interests - PRISM Pharma
Patents, Royalties, Other Intellectual Property - PRISM Pharma
Travel, Accommodations, Expenses - PRISM Pharma
Other Relationship - Eisai